Autoimmune Thyroid Disease in Psoriasis Patients: A Case-Control Study

Psoriasis is a common immunologically mediated inflammatory disease characterized by skin inflammation, epidermal hyperplasia, an increased risk of painful and destructive arthritis, cardiovascular morbidity, and psychosocial challenges. Some autoimmune diseases are mediated by stimulating or blocki...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2023-12, Vol.15 (12), p.e50197-e50197
Hauptverfasser: Prashant, Praveen, Garg, Renu, Kataria, Usha, Vashist, Sonia, Bansal, Piyush, Prakash, Gulshan, Dokwal, Sumit, Bansal, Abhishek
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e50197
container_issue 12
container_start_page e50197
container_title Curēus (Palo Alto, CA)
container_volume 15
creator Prashant, Praveen
Garg, Renu
Kataria, Usha
Vashist, Sonia
Bansal, Piyush
Prakash, Gulshan
Dokwal, Sumit
Bansal, Abhishek
description Psoriasis is a common immunologically mediated inflammatory disease characterized by skin inflammation, epidermal hyperplasia, an increased risk of painful and destructive arthritis, cardiovascular morbidity, and psychosocial challenges. Some autoimmune diseases are mediated by stimulating or blocking auto-antibodies. Auto-antibodies may act as antagonists and bind to hormone receptors, blocking receptor function. It may result in impaired secretion of mediators and gradual dysfunction of the affected organ, e.g., Graves disease and myasthenia gravis. This study was planned to evaluate the association between anti-thyroid peroxidase antibody (anti-TPO Ab) and anti-thyroglobulin antibody (anti-TG Ab) as biochemical markers in 30 clinically diagnosed psoriasis patients. This hospital-based, epidemiological case-control study was conducted in the Department of Biochemistry in collaboration with the Department of Dermatology, Venereology, and Leprology at Bhagat Phool Singh Government Medical College for Women, Khanpur Kalan, Sonepat, Haryana, India. Thirty subjects diagnosed clinically with psoriasis and an equal number of age-matched controls with no known autoimmune disease from the outpatient department were also enrolled. The following hormonal tests, i.e., thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), and antibodies, anti-TPO Ab and anti-TG Ab, were performed. The study period was one year. The data thus obtained was analyzed using SPSS Statistics version 26.0 (IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp). The significance level (p-value) was taken as
doi_str_mv 10.7759/cureus.50197
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10771958</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2920430302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c343t-a271edb744bd7eda26ace581af5f2a59dc0e77bc450efc22f2113951d5c62903</originalsourceid><addsrcrecordid>eNpdkc9LwzAcxYMobszdPEvBiwer-dEsjRcZ1akwcODuIUtTl9E2M2mE_fdGN8f09P3C-_B4jwfAOYI3jFF-q4LTwd9QiDg7An2MRnmaozw7Pvh7YOj9CkKIIMOQwVPQIznimFPSB5Nx6KxpmtDqZL7cOGvK5MF4Lb1OTJvMvHVGeuOTmeyMbjt_l4yTIqppYdvO2Tp560K5OQMnlay9Hu7uAMwnj_PiOZ2-Pr0U42mqSEa6VGKGdLlgWbYomS4lHkmlaY5kRSssKS8V1IwtVEahrhTGFUaIcIpKqkaYQzIA91vbdVg0ulQxkJO1WDvTSLcRVhrxV2nNUrzbTxGrM8RpHh2udg7OfgTtO9EYr3Rdy1bb4AXmCFPM8oxH9PIfurLBtbFepDDMCCQQR-p6SylnvXe62qdBUHxvJLYbiZ-NIn5x2GAP_y5CvgBPXo4y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920430302</pqid></control><display><type>article</type><title>Autoimmune Thyroid Disease in Psoriasis Patients: A Case-Control Study</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Prashant, Praveen ; Garg, Renu ; Kataria, Usha ; Vashist, Sonia ; Bansal, Piyush ; Prakash, Gulshan ; Dokwal, Sumit ; Bansal, Abhishek</creator><creatorcontrib>Prashant, Praveen ; Garg, Renu ; Kataria, Usha ; Vashist, Sonia ; Bansal, Piyush ; Prakash, Gulshan ; Dokwal, Sumit ; Bansal, Abhishek</creatorcontrib><description>Psoriasis is a common immunologically mediated inflammatory disease characterized by skin inflammation, epidermal hyperplasia, an increased risk of painful and destructive arthritis, cardiovascular morbidity, and psychosocial challenges. Some autoimmune diseases are mediated by stimulating or blocking auto-antibodies. Auto-antibodies may act as antagonists and bind to hormone receptors, blocking receptor function. It may result in impaired secretion of mediators and gradual dysfunction of the affected organ, e.g., Graves disease and myasthenia gravis. This study was planned to evaluate the association between anti-thyroid peroxidase antibody (anti-TPO Ab) and anti-thyroglobulin antibody (anti-TG Ab) as biochemical markers in 30 clinically diagnosed psoriasis patients. This hospital-based, epidemiological case-control study was conducted in the Department of Biochemistry in collaboration with the Department of Dermatology, Venereology, and Leprology at Bhagat Phool Singh Government Medical College for Women, Khanpur Kalan, Sonepat, Haryana, India. Thirty subjects diagnosed clinically with psoriasis and an equal number of age-matched controls with no known autoimmune disease from the outpatient department were also enrolled. The following hormonal tests, i.e., thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), and antibodies, anti-TPO Ab and anti-TG Ab, were performed. The study period was one year. The data thus obtained was analyzed using SPSS Statistics version 26.0 (IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp). The significance level (p-value) was taken as &lt;0.05. The mean age of psoriasis subjects was 37.83±12.89 years compared to 36.91±12.32 years in the control group and was found to be non-significant (p=0.432), reflecting a similar age distribution. A male preponderance was observed in the present study, where the psoriasis group consisted of 80% males and 20% females, while the control group had 60% males and 40% females. All six psoriasis patients diagnosed with autoimmune thyroid disease (AITD) were euthyroid at the time of enrollment, compared to only one control subject in a subclinical hypothyroid state. The mean values of anti-TPO Ab were 30.93±41.26 IU/mL in psoriasis patients and 11.39±28.42 IU/mL in the control group (p=0.001), while the mean values of anti-TG Ab were 11.21±27.69 IU/mL in psoriatic subjects and 2.49±9.05 IU/mL in the control group (p=0.004). No significant correlation between AITD and psoriasis was found when both parameters were analyzed statistically for correlation; even when one marker was considered, no significant correlation was found. The odds ratio was calculated to find an association between the disease and thyroid autoimmunity. The odds ratio was estimated to be 2.25 for psoriasis and the control group, with a confidence interval of 95% (0.77-6.59) and a p-value of 0.139, which was not statistically significant. Psoriasis, a dermatological disorder, has been seen as related to AITD. The role of early detection of anti-thyroid antibodies, i.e., anti-TPO Ab and anti-TG Ab, can be of prognostic value in AITD and psoriasis.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.50197</identifier><identifier>PMID: 38192953</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Age ; Allergy/Immunology ; Antibodies ; Autoimmune diseases ; Chi-square test ; Dermatology ; Females ; Hyperthyroidism ; Males ; Mann-Whitney U test ; Medical prognosis ; Pathology ; Psoriasis ; Quality control ; Skin ; Statistical analysis ; Thyroid diseases</subject><ispartof>Curēus (Palo Alto, CA), 2023-12, Vol.15 (12), p.e50197-e50197</ispartof><rights>Copyright © 2023, Prashant et al.</rights><rights>Copyright © 2023, Prashant et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2023, Prashant et al. 2023 Prashant et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c343t-a271edb744bd7eda26ace581af5f2a59dc0e77bc450efc22f2113951d5c62903</citedby><cites>FETCH-LOGICAL-c343t-a271edb744bd7eda26ace581af5f2a59dc0e77bc450efc22f2113951d5c62903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771958/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771958/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38192953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prashant, Praveen</creatorcontrib><creatorcontrib>Garg, Renu</creatorcontrib><creatorcontrib>Kataria, Usha</creatorcontrib><creatorcontrib>Vashist, Sonia</creatorcontrib><creatorcontrib>Bansal, Piyush</creatorcontrib><creatorcontrib>Prakash, Gulshan</creatorcontrib><creatorcontrib>Dokwal, Sumit</creatorcontrib><creatorcontrib>Bansal, Abhishek</creatorcontrib><title>Autoimmune Thyroid Disease in Psoriasis Patients: A Case-Control Study</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Psoriasis is a common immunologically mediated inflammatory disease characterized by skin inflammation, epidermal hyperplasia, an increased risk of painful and destructive arthritis, cardiovascular morbidity, and psychosocial challenges. Some autoimmune diseases are mediated by stimulating or blocking auto-antibodies. Auto-antibodies may act as antagonists and bind to hormone receptors, blocking receptor function. It may result in impaired secretion of mediators and gradual dysfunction of the affected organ, e.g., Graves disease and myasthenia gravis. This study was planned to evaluate the association between anti-thyroid peroxidase antibody (anti-TPO Ab) and anti-thyroglobulin antibody (anti-TG Ab) as biochemical markers in 30 clinically diagnosed psoriasis patients. This hospital-based, epidemiological case-control study was conducted in the Department of Biochemistry in collaboration with the Department of Dermatology, Venereology, and Leprology at Bhagat Phool Singh Government Medical College for Women, Khanpur Kalan, Sonepat, Haryana, India. Thirty subjects diagnosed clinically with psoriasis and an equal number of age-matched controls with no known autoimmune disease from the outpatient department were also enrolled. The following hormonal tests, i.e., thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), and antibodies, anti-TPO Ab and anti-TG Ab, were performed. The study period was one year. The data thus obtained was analyzed using SPSS Statistics version 26.0 (IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp). The significance level (p-value) was taken as &lt;0.05. The mean age of psoriasis subjects was 37.83±12.89 years compared to 36.91±12.32 years in the control group and was found to be non-significant (p=0.432), reflecting a similar age distribution. A male preponderance was observed in the present study, where the psoriasis group consisted of 80% males and 20% females, while the control group had 60% males and 40% females. All six psoriasis patients diagnosed with autoimmune thyroid disease (AITD) were euthyroid at the time of enrollment, compared to only one control subject in a subclinical hypothyroid state. The mean values of anti-TPO Ab were 30.93±41.26 IU/mL in psoriasis patients and 11.39±28.42 IU/mL in the control group (p=0.001), while the mean values of anti-TG Ab were 11.21±27.69 IU/mL in psoriatic subjects and 2.49±9.05 IU/mL in the control group (p=0.004). No significant correlation between AITD and psoriasis was found when both parameters were analyzed statistically for correlation; even when one marker was considered, no significant correlation was found. The odds ratio was calculated to find an association between the disease and thyroid autoimmunity. The odds ratio was estimated to be 2.25 for psoriasis and the control group, with a confidence interval of 95% (0.77-6.59) and a p-value of 0.139, which was not statistically significant. Psoriasis, a dermatological disorder, has been seen as related to AITD. The role of early detection of anti-thyroid antibodies, i.e., anti-TPO Ab and anti-TG Ab, can be of prognostic value in AITD and psoriasis.</description><subject>Age</subject><subject>Allergy/Immunology</subject><subject>Antibodies</subject><subject>Autoimmune diseases</subject><subject>Chi-square test</subject><subject>Dermatology</subject><subject>Females</subject><subject>Hyperthyroidism</subject><subject>Males</subject><subject>Mann-Whitney U test</subject><subject>Medical prognosis</subject><subject>Pathology</subject><subject>Psoriasis</subject><subject>Quality control</subject><subject>Skin</subject><subject>Statistical analysis</subject><subject>Thyroid diseases</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkc9LwzAcxYMobszdPEvBiwer-dEsjRcZ1akwcODuIUtTl9E2M2mE_fdGN8f09P3C-_B4jwfAOYI3jFF-q4LTwd9QiDg7An2MRnmaozw7Pvh7YOj9CkKIIMOQwVPQIznimFPSB5Nx6KxpmtDqZL7cOGvK5MF4Lb1OTJvMvHVGeuOTmeyMbjt_l4yTIqppYdvO2Tp560K5OQMnlay9Hu7uAMwnj_PiOZ2-Pr0U42mqSEa6VGKGdLlgWbYomS4lHkmlaY5kRSssKS8V1IwtVEahrhTGFUaIcIpKqkaYQzIA91vbdVg0ulQxkJO1WDvTSLcRVhrxV2nNUrzbTxGrM8RpHh2udg7OfgTtO9EYr3Rdy1bb4AXmCFPM8oxH9PIfurLBtbFepDDMCCQQR-p6SylnvXe62qdBUHxvJLYbiZ-NIn5x2GAP_y5CvgBPXo4y</recordid><startdate>20231208</startdate><enddate>20231208</enddate><creator>Prashant, Praveen</creator><creator>Garg, Renu</creator><creator>Kataria, Usha</creator><creator>Vashist, Sonia</creator><creator>Bansal, Piyush</creator><creator>Prakash, Gulshan</creator><creator>Dokwal, Sumit</creator><creator>Bansal, Abhishek</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20231208</creationdate><title>Autoimmune Thyroid Disease in Psoriasis Patients: A Case-Control Study</title><author>Prashant, Praveen ; Garg, Renu ; Kataria, Usha ; Vashist, Sonia ; Bansal, Piyush ; Prakash, Gulshan ; Dokwal, Sumit ; Bansal, Abhishek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c343t-a271edb744bd7eda26ace581af5f2a59dc0e77bc450efc22f2113951d5c62903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age</topic><topic>Allergy/Immunology</topic><topic>Antibodies</topic><topic>Autoimmune diseases</topic><topic>Chi-square test</topic><topic>Dermatology</topic><topic>Females</topic><topic>Hyperthyroidism</topic><topic>Males</topic><topic>Mann-Whitney U test</topic><topic>Medical prognosis</topic><topic>Pathology</topic><topic>Psoriasis</topic><topic>Quality control</topic><topic>Skin</topic><topic>Statistical analysis</topic><topic>Thyroid diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prashant, Praveen</creatorcontrib><creatorcontrib>Garg, Renu</creatorcontrib><creatorcontrib>Kataria, Usha</creatorcontrib><creatorcontrib>Vashist, Sonia</creatorcontrib><creatorcontrib>Bansal, Piyush</creatorcontrib><creatorcontrib>Prakash, Gulshan</creatorcontrib><creatorcontrib>Dokwal, Sumit</creatorcontrib><creatorcontrib>Bansal, Abhishek</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prashant, Praveen</au><au>Garg, Renu</au><au>Kataria, Usha</au><au>Vashist, Sonia</au><au>Bansal, Piyush</au><au>Prakash, Gulshan</au><au>Dokwal, Sumit</au><au>Bansal, Abhishek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autoimmune Thyroid Disease in Psoriasis Patients: A Case-Control Study</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2023-12-08</date><risdate>2023</risdate><volume>15</volume><issue>12</issue><spage>e50197</spage><epage>e50197</epage><pages>e50197-e50197</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Psoriasis is a common immunologically mediated inflammatory disease characterized by skin inflammation, epidermal hyperplasia, an increased risk of painful and destructive arthritis, cardiovascular morbidity, and psychosocial challenges. Some autoimmune diseases are mediated by stimulating or blocking auto-antibodies. Auto-antibodies may act as antagonists and bind to hormone receptors, blocking receptor function. It may result in impaired secretion of mediators and gradual dysfunction of the affected organ, e.g., Graves disease and myasthenia gravis. This study was planned to evaluate the association between anti-thyroid peroxidase antibody (anti-TPO Ab) and anti-thyroglobulin antibody (anti-TG Ab) as biochemical markers in 30 clinically diagnosed psoriasis patients. This hospital-based, epidemiological case-control study was conducted in the Department of Biochemistry in collaboration with the Department of Dermatology, Venereology, and Leprology at Bhagat Phool Singh Government Medical College for Women, Khanpur Kalan, Sonepat, Haryana, India. Thirty subjects diagnosed clinically with psoriasis and an equal number of age-matched controls with no known autoimmune disease from the outpatient department were also enrolled. The following hormonal tests, i.e., thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), and antibodies, anti-TPO Ab and anti-TG Ab, were performed. The study period was one year. The data thus obtained was analyzed using SPSS Statistics version 26.0 (IBM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp). The significance level (p-value) was taken as &lt;0.05. The mean age of psoriasis subjects was 37.83±12.89 years compared to 36.91±12.32 years in the control group and was found to be non-significant (p=0.432), reflecting a similar age distribution. A male preponderance was observed in the present study, where the psoriasis group consisted of 80% males and 20% females, while the control group had 60% males and 40% females. All six psoriasis patients diagnosed with autoimmune thyroid disease (AITD) were euthyroid at the time of enrollment, compared to only one control subject in a subclinical hypothyroid state. The mean values of anti-TPO Ab were 30.93±41.26 IU/mL in psoriasis patients and 11.39±28.42 IU/mL in the control group (p=0.001), while the mean values of anti-TG Ab were 11.21±27.69 IU/mL in psoriatic subjects and 2.49±9.05 IU/mL in the control group (p=0.004). No significant correlation between AITD and psoriasis was found when both parameters were analyzed statistically for correlation; even when one marker was considered, no significant correlation was found. The odds ratio was calculated to find an association between the disease and thyroid autoimmunity. The odds ratio was estimated to be 2.25 for psoriasis and the control group, with a confidence interval of 95% (0.77-6.59) and a p-value of 0.139, which was not statistically significant. Psoriasis, a dermatological disorder, has been seen as related to AITD. The role of early detection of anti-thyroid antibodies, i.e., anti-TPO Ab and anti-TG Ab, can be of prognostic value in AITD and psoriasis.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>38192953</pmid><doi>10.7759/cureus.50197</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2023-12, Vol.15 (12), p.e50197-e50197
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10771958
source PubMed Central Open Access; PubMed Central
subjects Age
Allergy/Immunology
Antibodies
Autoimmune diseases
Chi-square test
Dermatology
Females
Hyperthyroidism
Males
Mann-Whitney U test
Medical prognosis
Pathology
Psoriasis
Quality control
Skin
Statistical analysis
Thyroid diseases
title Autoimmune Thyroid Disease in Psoriasis Patients: A Case-Control Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A18%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autoimmune%20Thyroid%20Disease%20in%20Psoriasis%20Patients:%20A%20Case-Control%20Study&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Prashant,%20Praveen&rft.date=2023-12-08&rft.volume=15&rft.issue=12&rft.spage=e50197&rft.epage=e50197&rft.pages=e50197-e50197&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.50197&rft_dat=%3Cproquest_pubme%3E2920430302%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2920430302&rft_id=info:pmid/38192953&rfr_iscdi=true